Polymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results
Figure 3
PEF variability during the 4-week treatment period in the GlyGly16 (continuous line) and in pooled ArgArg16 and ArgGly16 patients (dashed line). Values are expressed as means with error bars. Between-groups differences: ; .
